# Comparison of Different Propofol Formulations With or Without Remifentanil

> **NCT01592162** · PHASE4 · COMPLETED · sponsor: **Hopital Foch** · enrollment: 409 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Propofol (Astra-Zeneca), NaCl 0.9%
- **DRUG:** propofol 1% (Astra-Zeneca) and remifentanil
- **DRUG:** propofol 1% (Astra-Zeneca) and remifentanil
- **DRUG:** Propofol (Astra-Zeneca), NaCl 0.9%
- **DRUG:** Propofol (Astra-Zeneca) and remifentanil
- **DRUG:** Propofol (Astra-Zeneca) and remifentanil
- **DRUG:** Propofol (B-Braun) and NaCl 0.9%
- **DRUG:** Propofol (B-Braun) and remifentanil
- **DRUG:** Propofol (B-Braun) and remifentanil

## Key facts

- **NCT ID:** NCT01592162
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01592162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01592162, "Comparison of Different Propofol Formulations With or Without Remifentanil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01592162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*